Skip to main content

Table 1 The differences in mutational frequencies among the three inflammatory response subtypes

From: Inflammatory response-based prognostication and personalized therapy decisions in clear cell renal cell cancer to aid precision oncology

Mutated gene

TMB

IR1

IR2

IR3

P

Adjusted p

BAP1

34 (10%)

13 (18.1%)

17 (8.0%)

4 (8.9%)

5.53E-02

1.52E-01

VHL

155 (47%)

30 (41.7%)

113 (53.1%)

12 (26.7%)

2.97E-03

1.63E-02

DST

25 (8%)

6 (8.3%)

14 (6.6%)

5 (11.1%)

5.02E-01

7.30E-01

SETD2

39 (12%)

8 (11.1%)

24 (11.3%)

7 (15.6%)

6.73E-01

8.23E-01

MUC16

23 (7%)

7 (9.7%)

14 (6.6%)

2 (4.4%)

5.31E-01

7.30E-01

DNAH9

17 (5%)

3 (4.2%)

11 (5.2%)

3 (6.7%)

8.68E-01

8.68E-01

LRP2

17 (5%)

3 (4.2%)

11 (5.2%)

3 (6.7%)

8.68E-01

8.68E-01

KDM5C

18 (6%)

2 (2.8%)

12 (5.6%)

4 (8.9%)

3.61E-01

7.30E-01

PBRM1

134 (41%)

20 (27.8%)

104 (48.8%)

10 (22.2%)

1.64E-04

1.80E-03

MTOR

23 (7%)

5 (6.9%)

11 (5.2%)

7 (15.6%)

5.33E-02

1.52E-01

TTN

68 (21%)

11 (15.3%)

47 (22.1%)

10 (22.2%)

4.68E-01

7.30E-01